Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zensei Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company specializing in the development, manufacture, and distribution of generic drugs and providing contract development and manufacturing organization (CDMO) services. As a member of the Nipro Group, the company focuses on oral solid dosage forms, including tablets, granules, and capsules. Zensei operates state-of-the-art manufacturing facilities in Kishiwada and Izumi, Osaka, with a combined production capacity of billions of tablets annually. The company is known for its "MAGOKORO" (sincerity) philosophy and its commitment to high-quality standards in the generic drug market. Its business model includes both its own brand of generic products and contract manufacturing for other pharmaceutical companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zensei Yakuhin.